Global Point of Care Molecular Diagnostics Market – Analysis and Forecast (2018-2024)

1. Point of Care Molecular Diagnostics Market

2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

3. Point of Care Molecular Diagnostics Market Molecular diagnosis is detection of specific sequence of DNA or RNA that may be associated with the disease. Point of care molecular diagnostics help healthcare professionals in the detection of diseases through molecular technologies in point-of-care settings. The global point of care molecular diagnostics market is growing at a significant rate due to the intensifying occurrence of infectious diseases, and increasing focus on decentralized diagnostics. Different types of products and services contributed to the point of care molecular diagnostics market size. The market has witnessed a high demand for assays & kits over the last few years, due to the intensifying occurrence of infectious diseases.

4. Point of Care Molecular Diagnostics Market The increasing demand for CLIA-waived molecular POC tests, increasing public awareness levels pertaining to pre-disease detection and increasing focus on decentralized diagnostics are the primary growth drivers for point of care molecular diagnostics market. It has become feasible to detect numerous viral and bacterial organisms precisely from a patient specimen with the launch of amplification methods for other nucleic acid and polymerase chain reaction. The Clinical Laboratory Improvement Amendments (CLIA) is the regulation for all the U.S. facilities which test human specimens. In January 2015, the FDA approved the first disclaimer under CLIA for a nucleic acid-based test.

5. Point of Care Molecular Diagnostics Market Major players in the industry are investing in the development of innovative and advanced products, which is strengthening their position in the market. For instance, in January 2017, Abbott received CE approval for Alinity System for blood and plasma screening. It is designed to screen blood and plasma faster and more efficiently within a smaller footprint. Abbott Laboratories, Danaher Corporation, Biomérieux Sa, Roche Diagnostics, Quidel, Meridian Bioscience, Mesa Biotech, Genepoc, DxNA, Atlas Genetics are some of the key players offering a point of care molecular diagnostics products.

6. For Sample Report :- https://www.vynzresearch.com/healthcare/point-of-care-molecular-diagnostics-market/request-sample www.vynzresearch.com